A detailed history of Group One Trading, L.P. transactions in Pro Qr Therapeutics N.V. stock. As of the latest transaction made, Group One Trading, L.P. holds 4,090 shares of PRQR stock, worth $7,443. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,090
Previous 9,690 57.79%
Holding current value
$7,443
Previous $22,000 72.73%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$1.65 - $2.39 $9,240 - $13,384
-5,600 Reduced 57.79%
4,090 $6,000
Q1 2024

May 10, 2024

SELL
$1.89 - $2.85 $16,473 - $24,840
-8,716 Reduced 47.35%
9,690 $22,000
Q4 2023

Feb 14, 2024

BUY
$1.15 - $2.21 $9,936 - $19,094
8,640 Added 88.47%
18,406 $36,000
Q3 2023

Nov 09, 2023

BUY
$1.3 - $1.77 $7,636 - $10,396
5,874 Added 150.92%
9,766 $12,000
Q2 2023

Aug 09, 2023

BUY
$1.62 - $2.32 $6,305 - $9,029
3,892 New
3,892 $6,000
Q3 2022

Nov 09, 2022

SELL
$0.74 - $0.89 $13,357 - $16,064
-18,050 Reduced 30.5%
41,126 $31,000
Q2 2022

Aug 11, 2022

BUY
$0.56 - $1.0 $9,525 - $17,009
17,009 Added 40.34%
59,176 $46,000
Q1 2022

May 12, 2022

SELL
$0.9 - $8.39 $7,141 - $66,574
-7,935 Reduced 15.84%
42,167 $38,000
Q4 2021

Feb 11, 2022

BUY
$6.58 - $8.44 $324,203 - $415,847
49,271 Added 5929.12%
50,102 $401,000
Q3 2021

Nov 12, 2021

SELL
$5.16 - $8.47 $82,905 - $136,087
-16,067 Reduced 95.08%
831 $7,000
Q2 2021

Aug 10, 2021

BUY
$5.75 - $7.59 $97,163 - $128,255
16,898 New
16,898 $114,000
Q3 2020

Nov 12, 2020

SELL
$4.79 - $6.3 $27,303 - $35,910
-5,700 Closed
0 $0
Q2 2020

Aug 13, 2020

BUY
$4.5 - $6.53 $360 - $522
80 Added 1.42%
5,700 $35,000
Q1 2020

May 13, 2020

SELL
$5.25 - $9.9 $137,991 - $260,211
-26,284 Reduced 82.38%
5,620 $31,000
Q4 2019

Feb 10, 2020

BUY
$5.84 - $10.51 $138,898 - $249,969
23,784 Added 292.91%
31,904 $316,000
Q3 2019

Nov 12, 2019

BUY
$5.76 - $9.44 $46,771 - $76,652
8,120 New
8,120 $47,000

Others Institutions Holding PRQR

About ProQR Therapeutics N.V.


  • Ticker PRQR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,362,096
  • Market Cap $130M
  • Description
  • ProQR Therapeutics N.V., a biopharmaceutical company, engages in the discovery and development of RNA-based therapeutics for the treatment of genetic disorders. It primarily develops sepofarsen that is in phase II/III clinical trial illuminate trial for treating leber congenital amaurosis 10 disease; and ultevursen, which is in phase II/III clin...
More about PRQR
Track This Portfolio

Track Group One Trading, L.P. Portfolio

Follow Group One Trading, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.